|
US20020037876A1
(en)
*
|
1998-06-25 |
2002-03-28 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
US6459003B1
(en)
|
1999-04-01 |
2002-10-01 |
Esperion Therapeutics, Inc. |
Ether compounds
|
|
AU2000265105A1
(en)
*
|
2000-08-02 |
2002-02-13 |
Pharmanutrients |
Methods and compositions for the prevention and treatment of syndrome x
|
|
AU2001290241A1
(en)
*
|
2000-09-20 |
2002-04-02 |
Kyowa Hakko Kogyo Co. Ltd. |
Tumor cell proliferation inhibitors
|
|
US7304093B2
(en)
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
CN1962596A
(zh)
|
2000-10-11 |
2007-05-16 |
埃斯佩里安医疗公司 |
用于控制胆固醇以及相关用途的酮化合物以及组合物
|
|
WO2002030884A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
MXPA03003021A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
|
|
JP2004531459A
(ja)
|
2000-10-11 |
2004-10-14 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
AU2003223930A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Novo Nordisk A/S |
Pharmaceutical use of boronic acids and esters thereof
|
|
US7335689B2
(en)
|
2003-01-23 |
2008-02-26 |
Esperion Therapeutics, Inc. |
Dihydroxyl compounds and compositions for cholesterol management and related uses
|
|
US7705177B2
(en)
|
2003-12-24 |
2010-04-27 |
Esperion Therapuetics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
US20090018199A1
(en)
*
|
2003-12-30 |
2009-01-15 |
Syndrome X Ltd. |
Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid
|
|
KR20050118057A
(ko)
*
|
2004-04-24 |
2005-12-15 |
김상희 |
아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
|
|
WO2007016525A2
(en)
|
2005-07-29 |
2007-02-08 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
WO2007137864A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Eucro European Contract Research Gmbh & Co. Kg |
Use of inhibitors of pp2c for treating or preventing arteriosclerosis
|
|
US7777071B2
(en)
|
2006-08-11 |
2010-08-17 |
Ssv Therapeutics, Inc. |
Production of carnitine conjugate intermediates
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
IL181577A0
(en)
*
|
2007-02-26 |
2007-07-04 |
Jacob Bar Tana |
Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
|
|
EP2431043A1
(en)
|
2007-05-23 |
2012-03-21 |
Amcol International Corporation |
Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
|
|
DE102007051339A1
(de)
*
|
2007-10-26 |
2009-04-30 |
Müller-Enoch, Dieter, Prof. Dr. |
Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
|
|
EP2085082A1
(en)
*
|
2008-01-29 |
2009-08-05 |
Nutromnia S.R.L. |
Treatment of cognitive decline
|
|
US8114995B2
(en)
|
2008-06-26 |
2012-02-14 |
Resverlogix Corp. |
Methods of preparing quinazolinone derivatives
|
|
ES2542835T3
(es)
|
2009-01-08 |
2015-08-12 |
Resverlogix Corporation |
Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
|
|
EP2381950B1
(en)
*
|
2009-01-14 |
2013-11-13 |
Vanas Oncology |
hydroxyhexadecanoic acid for the treatment of cancer
|
|
NZ617779A
(en)
|
2009-03-18 |
2015-08-28 |
Resverlogix Corp |
Novel anti-inflammatory agents
|
|
US8792614B2
(en)
*
|
2009-03-31 |
2014-07-29 |
Matthew R. Witten |
System and method for radiation therapy treatment planning using a memetic optimization algorithm
|
|
US9757368B2
(en)
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
KR101660578B1
(ko)
|
2009-09-03 |
2016-09-27 |
화이자 백신스 엘엘씨 |
Ｐｃｓｋ９ 백신
|
|
WO2012131504A1
(en)
|
2011-03-02 |
2012-10-04 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
PT2773354T
(pt)
|
2011-11-01 |
2019-07-17 |
Resverlogix Corp |
Formulações orais de libertação imediata para quinazolinonas substituídas
|
|
EP2787986B1
(en)
*
|
2011-12-08 |
2017-10-18 |
Syndromex Ltd. |
Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
EP3104877B1
(en)
|
2014-02-11 |
2020-01-22 |
The USA, as represented by The Secretary, Department of Health and Human Services |
Pcsk9 vaccine and methods of using the same
|
|
CN114984016A
(zh)
|
2015-03-13 |
2022-09-02 |
雷斯韦洛吉克斯公司 |
用于治疗补体相关疾病之组合物及治疗方法
|
|
MX392182B
(es)
|
2015-03-13 |
2025-03-21 |
Esperion Therapeutics Inc |
Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
US20180092874A1
(en)
*
|
2016-10-03 |
2018-04-05 |
Lincoln Memorial University |
Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
|
|
MX391168B
(es)
|
2017-07-07 |
2025-03-21 |
The Us Secretary Department Of Health & Human Services |
Derivados de acido graso y su uso.
|
|
CN112437765A
(zh)
|
2019-06-21 |
2021-03-02 |
艾斯柏伦治疗公司 |
贝派地酸的盐形式及其使用方法
|